Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Deficit, Unaudited

v3.23.3
Condensed Consolidated Statement of Stockholders' Deficit, Unaudited - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 355,301 $ 118,065,699 $ (122,594,000) $ (4,173,000)
Balance at beginning, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 1,931 18,069 20,000
Common stock issued on conversion of notes payable, shares 1,930,633      
Warrants issued with convertible notes 283,000 283,000
Common stock issued on exercise of warrants $ 8,594 297,406 306,000
Common stock issued on exercise of warrants, shares 8,593,828      
Fair value of options and warrants issued as compensation 31,000 31,000
Common stock issued on exercise of options $ 250 19,750 20,000
Common stock issued on exercise of options, shares 250,000      
Net loss (909,000) (909,000)
Ending balance, value at Sep. 30, 2022 $ 366,076 118,714,924 (123,503,000) (4,422,000)
Balance at ending, shares at Sep. 30, 2022 366,074,683      
Beginning balance, value at Jun. 30, 2022 $ 358,928 118,193,072 (123,066,000) (4,514,000)
Balance at beginning, shares at Jun. 30, 2022 358,926,888      
Common stock issued on conversion of notes payable $ 1,564 12,436 14,000
Common stock issued on conversion of notes payable, shares 1,563,967      
Warrants issued with convertible notes 283,000 283,000
Common stock issued on exercise of warrants $ 5,334 202,666 208,000
Common stock issued on exercise of warrants, shares 5,333,828      
Fair value of options and warrants issued as compensation 4,000 4,000
Common stock issued on exercise of options $ 250 19,750 20,000
Common stock issued on exercise of options, shares 250,000      
Net loss (437,000) (437,000)
Ending balance, value at Sep. 30, 2022 $ 366,076 118,714,924 (123,503,000) (4,422,000)
Balance at ending, shares at Sep. 30, 2022 366,074,683      
Beginning balance, value at Dec. 31, 2022 $ 376,075 119,075,925 (124,142,000) (4,690,000)
Balance at beginning, shares at Dec. 31, 2022 376,074,096      
Common stock issued on conversion of notes payable $ 11,585 241,415 253,000
Common stock issued on conversion of notes payable, shares 11,584,848      
Warrants issued with convertible notes 231,000 231,000
Common stock issued on exercise of warrants $ 1,317 48,683 50,000
Common stock issued on exercise of warrants, shares 1,316,661      
Fair value of options and warrants issued as compensation 34,000 34,000
Net loss (919,000) (919,000)
Ending balance, value at Sep. 30, 2023 $ 388,977 119,631,023 (125,061,000) (5,041,000)
Balance at ending, shares at Sep. 30, 2023 388,975,605      
Beginning balance, value at Jun. 30, 2023 $ 385,821 119,395,179 (124,760,000) (4,979,000)
Balance at beginning, shares at Jun. 30, 2023 385,819,422      
Common stock issued on conversion of notes payable $ 2,956 80,044 83,000
Common stock issued on conversion of notes payable, shares 2,956,184      
Warrants issued with convertible notes 128,000 128,000
Common stock issued on exercise of warrants $ 200 7,800 8,000
Common stock issued on exercise of warrants, shares 199,999      
Fair value of options and warrants issued as compensation 20,000 20,000
Net loss (301,000) (301,000)
Ending balance, value at Sep. 30, 2023 $ 388,977 $ 119,631,023 $ (125,061,000) $ (5,041,000)
Balance at ending, shares at Sep. 30, 2023 388,975,605